EP3082775A4 - Extruded extended release abuse deterrent pill - Google Patents

Extruded extended release abuse deterrent pill Download PDF

Info

Publication number
EP3082775A4
EP3082775A4 EP14871095.7A EP14871095A EP3082775A4 EP 3082775 A4 EP3082775 A4 EP 3082775A4 EP 14871095 A EP14871095 A EP 14871095A EP 3082775 A4 EP3082775 A4 EP 3082775A4
Authority
EP
European Patent Office
Prior art keywords
extended release
abuse deterrent
release abuse
deterrent pill
extruded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14871095.7A
Other languages
German (de)
French (fr)
Other versions
EP3082775A1 (en
Inventor
Edwin R. Thompson
Eric R. Thompson
Nicholas R. MYSLINSKI
Steven F. Kemeny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaceutical Manufacturing Research Services Inc
Original Assignee
Pharmaceutical Manufacturing Research Services Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/457,714 external-priority patent/US10195153B2/en
Application filed by Pharmaceutical Manufacturing Research Services Inc filed Critical Pharmaceutical Manufacturing Research Services Inc
Publication of EP3082775A1 publication Critical patent/EP3082775A1/en
Publication of EP3082775A4 publication Critical patent/EP3082775A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
EP14871095.7A 2013-12-17 2014-12-17 Extruded extended release abuse deterrent pill Withdrawn EP3082775A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201361917074P 2013-12-17 2013-12-17
US201361917120P 2013-12-17 2013-12-17
US201461980259P 2014-04-16 2014-04-16
US201461980254P 2014-04-16 2014-04-16
US14/457,714 US10195153B2 (en) 2013-08-12 2014-08-12 Extruded immediate release abuse deterrent pill
PCT/US2014/070942 WO2015095387A1 (en) 2013-12-17 2014-12-17 Extruded extended release abuse deterrent pill

Publications (2)

Publication Number Publication Date
EP3082775A1 EP3082775A1 (en) 2016-10-26
EP3082775A4 true EP3082775A4 (en) 2017-05-17

Family

ID=53403652

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14871095.7A Withdrawn EP3082775A4 (en) 2013-12-17 2014-12-17 Extruded extended release abuse deterrent pill

Country Status (5)

Country Link
EP (1) EP3082775A4 (en)
JP (2) JP6403780B2 (en)
AU (3) AU2014364800A1 (en)
CA (1) CA2934078C (en)
WO (1) WO2015095387A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049384A1 (en) * 1996-06-26 1997-12-31 Board Of Regents, The University Of Texas System Hot-melt extrudable pharmaceutical formulation
WO2010140007A2 (en) * 2009-06-05 2010-12-09 Euro-Celtique S.A. Dosage form
US20130028970A1 (en) * 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20140010873A1 (en) * 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
WO2015023675A2 (en) * 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1765303T5 (en) * 2004-07-01 2023-05-22 Grünenthal GmbH Oral dosage form safeguarded against abuse
US20080152595A1 (en) * 2004-11-24 2008-06-26 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
DE102007011485A1 (en) * 2007-03-07 2008-09-11 Grünenthal GmbH Dosage form with more difficult abuse
EP2838536B1 (en) * 2012-04-18 2017-08-09 Mallinckrodt LLC Immediate release pharmaceutical compositions with abuse deterrent properties

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049384A1 (en) * 1996-06-26 1997-12-31 Board Of Regents, The University Of Texas System Hot-melt extrudable pharmaceutical formulation
WO2010140007A2 (en) * 2009-06-05 2010-12-09 Euro-Celtique S.A. Dosage form
US20130028970A1 (en) * 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20140010873A1 (en) * 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
WO2015023675A2 (en) * 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015095387A1 *

Also Published As

Publication number Publication date
WO2015095387A1 (en) 2015-06-25
CA2934078C (en) 2019-08-06
AU2018253567A1 (en) 2018-11-08
JP2019001816A (en) 2019-01-10
JP2017503780A (en) 2017-02-02
AU2018253567B2 (en) 2019-05-23
AU2019216710A1 (en) 2019-09-12
EP3082775A1 (en) 2016-10-26
JP6403780B2 (en) 2018-10-10
CA2934078A1 (en) 2015-06-25
JP6678212B2 (en) 2020-04-08
AU2014364800A1 (en) 2016-07-07

Similar Documents

Publication Publication Date Title
EP3003271A4 (en) Abuse deterrent immediate release formulation
EP3039046A4 (en) Polyanionic polymers
EP3030566A4 (en) Aza-pyridone compounds and uses thereof
EP3090423A4 (en) Physical object discovery
EP2968182B8 (en) Abuse deterrent solid dosage form for immediate release with functional score
EP3030213A4 (en) Pill feeder
EP3008094A4 (en) Bis-biotinylation tags
EP3055288A4 (en) Antidiabetic tricyclic compounds
EP3003039A4 (en) Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
EP3088283A4 (en) Blinker device
EP3030519A4 (en) Tricyclic benzoxaborole compounds and uses thereof
EP3068768A4 (en) Antidiabetic tricyclic compounds
EP3057621A4 (en) Polymeric radiation-sources
EP3094785A4 (en) Hydrofission barrier
EP3068388A4 (en) Neuroprotective compounds and use thereof
EP2991648A4 (en) Antimicrobial potentiators
EP3062778A4 (en) Immediate release abuse-deterrent granulated dosage forms
EP3031607A4 (en) Multilayer molding
EP3048923B8 (en) Protection device with symmetry mechanism
EP3053943A4 (en) Ultraviolet-ray-absorbing polycarbonate
GB201600342D0 (en) Chewable tablet
EP3069714A4 (en) Tablet
EP3087240A4 (en) Spacing mechanism
EP3082775A4 (en) Extruded extended release abuse deterrent pill
EP3032948A4 (en) Extruded immediate release abuse deterrent pill

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160713

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170413

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/36 20060101ALI20170408BHEP

Ipc: A61K 9/22 20060101AFI20170408BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180605

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210112